Conference to feature expert-driven content on replacing passwords with passkeys; early bird discounts available through August 18 CARLSBAD, Calif., June 6, 2023 /PRNewswire/ -- The FIDO Alliance...

Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced Matthew Roden, PhD,...

Akeso, Inc. (9926.HK) ("Akeso") released two-year updated data from a Phase Ib/II clinical study of cadonilimab – a first-in-class PD-1/CTLA-4 bispecific antibody developed by Akeso – in...

- Marking the first phase of the company's second Bio Campus, Plant 5 is expected to have shortest construction timeline - Samsung Biologics will maintain the world's largest biomanufacturing...

Customers gain industry expertise, data, and best practices to streamline product development PLEASANTON, Calif., June 6, 2023 /PRNewswire/ -- 2023 Veeva R&D and Quality Summit, Europe — Veeva...